Prab: CSV import

2024-03-06T04:14:45Z

CSV import

New page

[[File:Imiloxan.png|thumb|{{PAGENAME}}]]<br>'''Imiloxan''' is a [[pharmacological]] agent that is classified as an [[alpha-adrenergic antagonist]]. It is primarily used in scientific research to study the [[adrenergic system]] and its role in various physiological and pathological processes.

== Pharmacology ==

[[Imiloxan]] is a selective [[alpha-2 adrenergic receptor]] antagonist. The alpha-2 adrenergic receptors are a subtype of [[adrenergic receptors]], which are a group of [[G protein-coupled receptors]] that are targets for the [[catecholamines]], especially [[norepinephrine]] and [[epinephrine]]. By blocking the action of these receptors, Imiloxan can increase the release of norepinephrine and other neurotransmitters, leading to increased [[neuronal activity]].

== Uses ==

Imiloxan is primarily used in [[neuroscience]] research to study the role of the adrenergic system in various physiological and pathological processes. For example, it has been used to investigate the role of the adrenergic system in [[anxiety]] and [[depression]], [[cardiovascular disease]], and [[neurodegenerative diseases]] such as [[Parkinson's disease]] and [[Alzheimer's disease]].

== Side Effects ==

As with any pharmacological agent, Imiloxan can have side effects. These can include [[hypertension]] (high blood pressure), [[tachycardia]] (rapid heart rate), and [[arrhythmias]] (irregular heart rhythms). However, these side effects are generally rare and are more likely to occur with higher doses.

== See Also ==

* [[Adrenergic antagonist]]
* [[Alpha-2 adrenergic receptor]]
* [[G protein-coupled receptor]]
* [[Norepinephrine]]
* [[Epinephrine]]

[[Category:Pharmacology]]
[[Category:Neuroscience]]
[[Category:Adrenergic antagonists]]
{{Pharmacology-stub}}

Imiloxan - Revision history

Prab: CSV import